ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Monaghan Medical Wins 2024 AARC Zenith Award

PLATTSBURGH, N.Y., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Monaghan Medical Corp., an innovator in the development and manufacturing of respiratory devices, proudly announces its recognition as a recipient of the prestigious 2024 Zenith Award, presented by the American Association for Respiratory Care (AARC). This accolade reaffirms Monaghan Medical's commitment to excellence in the field of respiratory care.

The 2024 AARC Zenith Award recognizes outstanding contributions in the respiratory care profession. Monaghan was recognized by AARC members for their exceptional products, accessible sales staff, responsiveness, service record, truth in advertising, and unwavering support of the respiratory care profession.

"The AARC Zenith Award is the 'people's choice' award of the respiratory care profession, and we are honored to have earned this distinction," said Bill Seitz, President at Monaghan Medical. "Our commitment to providing top-quality products and support to respiratory therapists has been recognized by those at the forefront of patient care, and we are deeply grateful."

The award will be formally presented to Monaghan Medical at AARC’s International Respiratory Congress in Orlando, Florida. With more than 47,000 members, AARC is the leading national and international professional association for respiratory care professionals and allied health practitioners.

Dominic P. Coppolo, Senior Vice President of Clinical and Hospital Marketing
Monaghan Medical Corp.
Phone: 800-343-9071
Email: dcoppolo@monaghanmed.com
Website: http://www.monaghanmed.com

ABOUT MONAGHAN MEDICAL
Headquartered in Plattsburgh, New York, Monaghan Medical is a leader in the research, development, manufacture, and marketing of respiratory devices to manage acute and chronic pulmonary illnesses and diseases like asthma and chronic obstructive pulmonary disease (COPD). MMC’s mission is to provide the respiratory community with quality, researched, and innovative devices to help people breathe easier.

For more information about Monaghan Medical products, please visit www.monaghanmed.com

ABOUT THE AMERICAN ASSOCIATION FOR RESPIRATORY CARE (AARC)
With more than 47,000 members, the AARC is the leading national and international professional association for respiratory care whose ranks include respiratory therapists and allied health professionals that assist physicians in the treatment of lung disorders and related ailments. The AARC encourages and promotes professional excellence, advances the science and practice of respiratory care, and serves as an advocate for patients, their families, the public, and the profession.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3e1f2764-8e3d-47e2-ab52-456fdd828dce


Recent Quotes

View More
Symbol Price Change (%)
AMZN  214.33
+0.00 (0.00%)
AAPL  260.83
+0.00 (0.00%)
AMD  203.23
+0.00 (0.00%)
BAC  48.56
+0.00 (0.00%)
GOOG  306.93
+0.00 (0.00%)
META  654.07
+0.00 (0.00%)
MSFT  405.76
+0.00 (0.00%)
NVDA  184.77
+0.00 (0.00%)
ORCL  149.40
+0.00 (0.00%)
TSLA  399.24
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.